Trials / Completed
CompletedNCT06368024
Establishment of Delphi-MD Safety Performance and Reliability
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 263 (actual)
- Sponsor
- QuantalX Neuroscience · Industry
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
A retrospective analysis of collected datasets. In this study we aim to establish Delphi-MD's safety and performance reliability for assessment and monitoring of Transcranial Magnetic Stimulation (TMS) Evoked Potentials (TEPs) as neurophysiological measurements.
Detailed description
A retrospective analysis of collected datasets. In this study we aim to establish Delphi-MD's safety and reliability for assessment and monitoring of TEP's as neurophysiological measurements. Safety: Upper limit of the 95% CI of the device related serious adverse event (SAE) rate is less than or equal to 3.6% Performance: Demonstrate differentiation of relevant clinical groups Reliability: An acceptable mean Interclass correlation (ICC) statistic (six stimulation) is at least 0.6 Additionally, the within subject variability should be lower than the between subject variability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | This is a retrospective analysis study of data collected with a diagnostic medical device | Transcranial Magnetic stimulation and Electroencephalogram |
Timeline
- Start date
- 2023-11-28
- Primary completion
- 2023-11-28
- Completion
- 2023-11-28
- First posted
- 2024-04-16
- Last updated
- 2024-04-26
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT06368024. Inclusion in this directory is not an endorsement.